DUBLIN, Dec. 18, 2017 /PRNewswire/ --
The "Europe Glaucoma Market and Competitive Landscape - 2017" report has been added to Research and Markets' offering.
The latest research, Europe Glaucoma Market and Competitive Landscape - 2017, provides comprehensive insights into Glaucoma pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Glaucoma market size and drug sales. This research also provides insights into Glaucoma epidemiology and late stage pipeline.
The report is classified into nine sections - Glaucoma overview with definitions, symptoms, etiology, diagnosis, treatment options; Glaucoma pipeline insights covering late stage clinical trials pipeline; Glaucoma prevalence trends by countries; Glaucoma market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries. The research scope includes EU5 countries - Germany, France, Italy, Spain, UK, Europe.
Research Scope:
- Glaucoma pipeline: Find out the drugs in clinical trials for Glaucoma by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by company
- Glaucoma epidemiology: Find out the prevalence of Glaucoma by countries - Europe, Germany, France, Italy, Spain, UK, Japan; prevalence forecast to 2025
- Glaucoma products: Identify key products marketed and prescribed for Glaucoma by brand name, by molecule, by company, by branded / generic, by countries - Europe, Germany, France, Italy, Spain, UK, Japan
- Glaucoma market size: Find out the market size for Glaucoma drugs by countries - Europe, Germany, France, Italy, Spain, UK, Japan; Find out how the market advanced from 2012
- Glaucoma drug sales: Find out the sales of Glaucoma drugs by countries - Europe, Germany, France, Italy, Spain, UK
- Glaucoma drugs sales forecast: Sales forecast for Glaucoma drugs to 2021 by countries - Europe, Germany, France, Italy, Spain, UK, Japan
- Glaucoma market share analysis: Find out the market shares of Glaucoma drugs and outlook by countries - Europe, Germany, France, Italy, Spain, UK, Japan
Benefits of this Research
- Evaluate commercial market opportunities for Glaucoma drugs
- Synthesize insights for business development & licensing
- Track market size, competitor drug sales, market shares in Glaucoma market
- Develop in-depth knowledge of competition and markets
- Analyze sales data to update your brand planning trackers
- Develop tactics and strategies to take advantage of opportunities in the market
- Track market trends and analyze key events in Glaucoma market
- Develop forecast models, healthcare frameworks, or economic models
- Answer key business questions; supports decision making in R&D to long term marketing strategies
Key Topics Covered:
1. Glaucoma: Disease Overview
2. Glaucoma Pipeline Insights
3. Glaucoma Epidemiology Analysis
4. Germany Glaucoma Market Insights
5. France Glaucoma Market Insights
6. Italy Glaucoma Market Insights
7. Spain Glaucoma Market Insights
8. UK Glaucoma Market Insights
9. Europe Glaucoma Market Insights
For more information about this report visit https://www.researchandmarkets.com/research/wx6hct/europe_glaucoma?w=5
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
